The South San Francisco, Calif.-based developer of cell and gene therapies said Monday that it inked a securities purchase agreement with certain investors for a private placement of 16,713 ...
Senti Biosciences, Inc. (NASDAQ:SNTI) stock is skyrocketing on Monday, with a strong session volume of 73.4 million compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback